Page 19 - JCBP-1-2

Journal of Clinical and
Basic Psychosomatics Melatonin for dementia therapy

dementia. Physiol Int, 105: 38–52. 93. Imbesi M, Uz T, Dzitoyeva S, et al., 2008, Stimulatory effects
of a melatonin receptor agonist, ramelteon, on BDNF in
https://doi.org/10.1556/2060.105.2018.1.1
mouse cerebellar granule cells. Neurosci Lett, 439: 34–36.
91. Chen BH, Park JH, Lee YL, et al., 2018, Melatonin improves
vascular cognitive impairment induced by ischemic stroke https://doi.org/10.1016/j.neulet.2008.04.099
by remyelination via activation of ERK1/2 signaling 94. Lauterbach EC, Kuppuswamy PS, Greenway LL, 2010,
and restoration of glutamatergic synapses in the gerbil Differential pharmacological responses of catatonia-like
hippocampus. Biomed Pharmacother, 108: 687–697. signs in frontotemporal dementia. Neurocase, 16: 436–
450.
https://doi.org/10.1016/j.biopha.2018.09.077
https://doi.org/10.1080/13554791003623326
92. Shen D, Tian X, Sang W, et al., 2016, Effect of melatonin
and resveratrol against memory impairment and 95. Callegari I, Mattei C, Benassi F, et al., 2023, Agomelatine
hippocampal damage in a rat model of vascular dementia. improves apathy in frontotemporal dementia. Neurodegener
Neuroimmunomodulation, 23: 318–331. Dis, 16: 352–356.
https://doi.org/10.1159/000454681 https://doi.org/10.1159/000445873

Volume 1 Issue 2 (2023) 13 https://doi.org/10.36922/jcbp.1174